An Open-Label Extension and Safety Monitoring Study

Project: Research project

Project Details

Description

An Open-Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase III Studies
StatusActive
Effective start/end date4/1/154/30/21

Funding

  • HOFFMANN-LA ROCHE PHARMACEUTICALS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.